To date, the only disease-modifying treatment strategy for allergic rhinitis and asthma is allergen immunotherapy (AIT). There is evidence that AIT improves allergic rhinitis and asthma, such as reducing symptom severity and medication use and improving of quality of life, with a long-lasting effect after the end of the course. The recent clinical trials evidenced AIT effectiveness and safety in allergic asthma. Consequently, the current version of the GINA (Global Initiative for Asthma) guidelines recommend AIT as an add-on therapy for asthma. There is also evidence that AIT may exert preventive activity on the possible progression from allergic rhinitis to asthma in children and the onset of new sensitizations. (www.actabiomedica.it).

Allergen immunotherapy in children and adolescents with respiratory diseases / Tosca, M. A.; Licari, A.; Olcese, R.; Castagnoli, R.; Marseglia, A.; Marseglia, G. L.; Del Giudice, M. M.; Martelli, A.; Calvani, M.; Caffarelli, C.; Duse, M.; Cravidi, C.; Cardinale, F.; Ciprandi, G.. - In: ACTA BIO-MEDICA DE L'ATENEO PARMENSE. - ISSN 0392-4203. - 91:11-S(2020), pp. 1-4. [10.23750/abm.v91i11-S.10309]

Allergen immunotherapy in children and adolescents with respiratory diseases

Caffarelli C.;
2020-01-01

Abstract

To date, the only disease-modifying treatment strategy for allergic rhinitis and asthma is allergen immunotherapy (AIT). There is evidence that AIT improves allergic rhinitis and asthma, such as reducing symptom severity and medication use and improving of quality of life, with a long-lasting effect after the end of the course. The recent clinical trials evidenced AIT effectiveness and safety in allergic asthma. Consequently, the current version of the GINA (Global Initiative for Asthma) guidelines recommend AIT as an add-on therapy for asthma. There is also evidence that AIT may exert preventive activity on the possible progression from allergic rhinitis to asthma in children and the onset of new sensitizations. (www.actabiomedica.it).
2020
Allergen immunotherapy in children and adolescents with respiratory diseases / Tosca, M. A.; Licari, A.; Olcese, R.; Castagnoli, R.; Marseglia, A.; Marseglia, G. L.; Del Giudice, M. M.; Martelli, A.; Calvani, M.; Caffarelli, C.; Duse, M.; Cravidi, C.; Cardinale, F.; Ciprandi, G.. - In: ACTA BIO-MEDICA DE L'ATENEO PARMENSE. - ISSN 0392-4203. - 91:11-S(2020), pp. 1-4. [10.23750/abm.v91i11-S.10309]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2880968
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? ND
social impact